News
06-23-2015, 03:02 AM
Pretreatment cytokine levels, specifically soluble TNF receptor type two (sTNF-RII), are associated with reduced memory performance among newly-diagnosed, post-menopausal breast cancer patients prior...
More... (http://www.medicalnewstoday.com/releases/295748.php)
More... (http://www.medicalnewstoday.com/releases/295748.php)